Search Results
Active Filters
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Nov 12, 2025, 16:05 ET Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update
primary endpoint in the NEPHRO CRRT study. These conditions may be waived by the investors at any time. The financing was led by CorMedix, Inc. (Nasdaq: CRMD) and supported by existing investors, Nantahala Capital, Rosalind Advisors, and Rock Springs Capital, and includes several new institutional investors.
More news about: Talphera, Inc.
Oct 21, 2025, 08:30 ET Talphera Announces the Appointment of Joe Todisco to Board of Directors
of innovative therapies for use in medically supervised settings, today announced the appointment of Joe Todisco, the CEO of CorMedix Inc. (Nasdaq: CRMD) to its Board of Directors. In September 2025, CorMedix made a strategic investment in Talphera as part of the
More news about: Talphera, Inc.